SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-17-001564
Filing Date
2017-03-14
Accepted
2017-03-14 16:23:56
Documents
84
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2231216z10-k.htm 10-K 1672931
2 EX-21.1 a2231216zex-21_1.htm EX-21.1 7294
3 EX-23.1 a2231216zex-23_1.htm EX-23.1 2847
4 EX-31.1 a2231216zex-31_1.htm EX-31.1 8858
5 EX-31.2 a2231216zex-31_2.htm EX-31.2 8866
6 EX-32 a2231216zex-32.htm EX-32 7417
13 G70484.JPG g70484.jpg GRAPHIC 43500
  Complete submission text file 0001047469-17-001564.txt   9667454

Data Files

Seq Description Document Type Size
7 EX-101.INS cldx-20161231.xml EX-101.INS 2580764
8 EX-101.SCH cldx-20161231.xsd EX-101.SCH 64779
9 EX-101.CAL cldx-20161231_cal.xml EX-101.CAL 80789
10 EX-101.LAB cldx-20161231_lab.xml EX-101.LAB 655698
11 EX-101.PRE cldx-20161231_pre.xml EX-101.PRE 450948
12 EX-101.DEF cldx-20161231_def.xml EX-101.DEF 235063
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 17688322
SIC: 2835 In Vitro & In Vivo Diagnostic Substances